Tuberculosis News and Research

Latest Tuberculosis News and Research

UCB seeks FDA and EMA marketing authorization for Cimzia to treat active psoriatic arthritis

UCB announced today two new regulatory filings with the US Food and Drug Administration (FDA) and with the European Medicines Agency (EMA) to extend the marketing authorization for Cimzia (certolizumab pegol) for the treatment of adult patients with active psoriatic arthritis (PsA) and for adult patients with active axial spondyloarthritis (axSpA).

20 Feb 2013

Outstanding U.S. and Canadian scientists to receive Sloan Research Fellowships for 2013

The Alfred P. Sloan Foundation is pleased to announce the selection of 126 outstanding U.S. and Canadian researchers as recipients of Sloan Research Fellowships for 2013.

20 Feb 2013

AIDS-free generation is within reach but only with fully-funded Global Fund

In the Huffington Post's "Impact" blog, ACTION Director Kolleen Bouchane highlights President Barack Obama's mention of global development and global health in Tuesday's State of the Union address.

16 Feb 2013

Having launched PEPFAR, George W. Bush is greatest humanitarian to serve U.S. presidency

In a post in Foreign Policy's "Democracy Lab" blog, Christian Caryl, a senior fellow at the Legatum Institute and the blog's editor, asks, "Which United States president will go down in history as the greatest humanitarian to have served in the office?" He writes, "I'd suggest that there's one president whose contribution dwarfs all the others" -- George W. Bush.

16 Feb 2013

China's new first lady has ability to influence public health activism

In an opinion piece published on contextChina, Robert O'Brien, a PhD candidate in international relations at the University of Oxford, examines how China's new first lady, acclaimed folk singer Peng Liyuan, might influence public health activism in the country.

15 Feb 2013

Improving tuberculosis (TB) diagnosis: an interview with Professor Madhukar Pai, MD, PhD

TB is an infectious disease caused by Mycobacterium tuberculosis. Nearly 9 million people develop TB every year, and TB kills nearly 1.4 million individuals each year. While the incidence of TB has steadily declined in the west, it remains a huge public health problem in many developing countries, with India having the highest burden.

15 Feb 2013

Xpert diagnosis of TB and its drug resistant strains

The use of a novel, diagnostic test called Xpert is both sensitive and specific in detecting tuberculosis and rifampicin resistance, report US researchers.

14 Feb 2013

The Atlantic examines 'paradigm shift' in global health response

"The world has an 'historic opportunity' to contain and end three of humanity's deadliest scourges by focusing on their 'hot zones,' according to Mark Dybul, the newly appointed director of the Geneva-based Global Fund to Fight AIDS, Tuberculosis, and Malaria," the Atlantic reports in an article examining a "paradigm shift" in the global health response.

14 Feb 2013

AIDS.gov blog examines Global Fund's future

"During January's World Economic Forum, international leaders welcomed former U.S. Global AIDS Coordinator Mark Dybul as the new head of the Global Fund to Fight AIDS, Tuberculosis and Malaria," Deborah Derrick, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, writes in the AIDS.gov blog.

13 Feb 2013

U.S. News examines growing threat of drug-resistant TB

U.S. News & World Report examines the growing epidemic of drug-resistant tuberculosis (TB), highlighting a "new paper published earlier this week in the Centers for Disease Control and Prevention's Emerging Infectious Diseases journal warn[ing] that the first cases of 'totally drug-resistant' tuberculosis have been found in South Africa and that the disease is 'virtually untreatable."

13 Feb 2013

New centre to boost development of drugs against TB, malaria and African sleeping sickness

A major new centre to boost the development of drugs to tackle the foremost diseases of the developing world is to be created at the University of Dundee.

13 Feb 2013

WHO-sponsored meeting discusses post-2015 goals for tuberculosis

Tuberculosis (TB) experts gathered in Geneva on Wednesday for a WHO-sponsored two-day meeting "to discuss a consensus on the appropriate post-2015 tuberculosis goals," Nature reports.

10 Feb 2013

Advocates come together to mobilize resources for Global Fund to fight AIDS, TB, malaria

"Over the last two weeks, a series of meetings were held in Amsterdam in the Netherlands -- advocates and people from the communities affected by HIV/AIDS, tuberculosis [TB] and malaria came together to strategize and decide on courses of action to take in this critical year of replenishing the Global Fund to Fight AIDS, Tuberculosis and Malaria," Lucy Chesire, executive director and secretary to the board of the TB ACTION Group, writes in the Huffington Post's "Impact" blog.

10 Feb 2013

Washington Post examines relationship between counterfeit drugs, rise of drug-resistant TB

The Washington Post examines the emergence of drug-resistant strains of tuberculosis (TB) around the world, writing, "One culprit in the rise of untreatable TB is counterfeit drugs, which can undermine treatment efforts by packing insufficient active ingredients to fully kill off bacteria, breeding new, stronger super-strains of the disease."

7 Feb 2013

First new TB vaccine in century fails initial testing

The first of a series of new vaccines that have been developed to combat tuberculosis failed to show efficacy compared with placebo in South African infants, show results from a phase II trial.

7 Feb 2013

Experimental TB vaccine does not protect infants, study shows

"Hopes that a much needed new tuberculosis [TB] vaccine was on the way, the first for 90 years, have been dashed by trial results showing it did not protect babies against the disease," the Guardian reports.

6 Feb 2013

TB vaccine candidate trial results are 'landmark' in fight against disease

"Today marks an important landmark for the fight against tuberculosis (TB)," with the publication in the Lancet of clinical trial results showing the TB vaccine candidate MVA85A "was no more effective in protecting infants from developing pulmonary TB than" the standard Bacillus Calmette-Guerin (BCG) vaccine, Peggy Johnston, senior program officer at the Bill & Melinda Gates Foundation, writes in the foundation's "Impatient Optimists" blog.

6 Feb 2013

Researchers, organizations urge Secretary of State Kerry to support AIDS funding

"Saying they are 'gravely concerned about reports that the Obama Administration's FY 2014 budget requests for PEPFAR and the Global Fund to Fight AIDS, Tuberculosis and Malaria fail to provide adequate resources,' researchers and physicians from programs, centers and institutions leading the international AIDS response sent a letter to Secretary of State John Kerry Friday, urging him to speak up for funding that will back policy and pursue the goal of an AIDS-free generation," the Center for Global Health Policy's "Science Speaks" blog reports.

6 Feb 2013

CDC, State Department, World Bank should lead fight against fake, substandard TB drugs

"Thanks to billions of dollars spent on diagnosis and treatment of tuberculosis (TB) over the past decade, deaths and infections are slowly declining," but "fake and poorly made antibiotics are being widely used to treat tuberculosis," according to a study "to be published Tuesday in the International Journal of Tuberculosis and Lung Disease," Roger Bate, a resident scholar at the American Enterprise Institute and an author of the study, writes in a New York Times opinion piece.

6 Feb 2013

Viewpoints: Sen. Hatch's prescription for safeguarding entitlements; Medicare crackdown on CVS drug program; JFK's mental health vision failing

American families are used to working with dollar amounts starting with hundreds and thousands. But the fiscal situation of our country requires us to act in terms of billions and trillions. ... Unfortunately, waiting until the last minute to stop a crisis has become standard operating procedure in Washington. But that isn't how we should be tackling our debt or safeguarding Medicare and Medicaid.

5 Feb 2013

Tuberculosis News and Research

Latest Tuberculosis News and Research

UCB seeks FDA and EMA marketing authorization for Cimzia to treat active psoriatic arthritis

Outstanding U.S. and Canadian scientists to receive Sloan Research Fellowships for 2013

AIDS-free generation is within reach but only with fully-funded Global Fund

Having launched PEPFAR, George W. Bush is greatest humanitarian to serve U.S. presidency

China's new first lady has ability to influence public health activism

Improving tuberculosis (TB) diagnosis: an interview with Professor Madhukar Pai, MD, PhD

Xpert diagnosis of TB and its drug resistant strains

The Atlantic examines 'paradigm shift' in global health response

AIDS.gov blog examines Global Fund's future

U.S. News examines growing threat of drug-resistant TB

New centre to boost development of drugs against TB, malaria and African sleeping sickness

WHO-sponsored meeting discusses post-2015 goals for tuberculosis

Advocates come together to mobilize resources for Global Fund to fight AIDS, TB, malaria

Washington Post examines relationship between counterfeit drugs, rise of drug-resistant TB

First new TB vaccine in century fails initial testing

Experimental TB vaccine does not protect infants, study shows

TB vaccine candidate trial results are 'landmark' in fight against disease

Researchers, organizations urge Secretary of State Kerry to support AIDS funding

CDC, State Department, World Bank should lead fight against fake, substandard TB drugs

Viewpoints: Sen. Hatch's prescription for safeguarding entitlements; Medicare crackdown on CVS drug program; JFK's mental health vision failing

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Tuberculosis News and Research

Latest Tuberculosis News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in